Grande área: Saúde
Objetivo: The Clinical Research Award program supports early stage pilot clinical trials of candidate therapeutics, or interventions for treatment of physical or psychosocial manifestations of NF1, NF2, and schwannomatosis. This grant mechanism also includes adjunct studies, such as the development of biomarkers, imaging protocols, and other clinical trial tools.
Inscrições: até 17 de agosto de 2020
Mais informações no site.